Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3,749	3,766	3,349	1,424	3,042	3,567
Market Cap Growth	40.85%	12.44%	135.22%	-53.20%	-14.70%	4142.51%
Enterprise Value	3,606	3,566	3,243	1,387	2,909	3,367
PE Ratio	-	-15.74	-17.90	-10.92	-29.57	-52.19
PS Ratio	14.93	13.92	66.94	-	-	-
PB Ratio	26.03	19.72	30.57	91.10	26.74	19.96
P/FCF Ratio	-19.55	-25.86	-28.58	-13.12	-38.76	-76.89
P/OCF Ratio	-19.62	-25.96	-28.75	-13.16	-38.78	-76.91
EV/Sales Ratio	14.37	13.18	64.82	-	-	-
EV/EBITDA Ratio	-12.80	-15.95	-18.61	-11.23	-29.00	-50.10
EV/EBIT Ratio	-12.43	-15.38	-18.04	-11.12	-28.97	-50.07
EV/FCF Ratio	-18.82	-24.48	-27.67	-12.78	-37.05	-72.57
Debt / Equity Ratio	1.31	0.98	0.86	3.18	0.44	0.11
Debt / EBITDA Ratio	-0.66	-0.83	-0.54	-0.40	-0.50	-0.30
Debt / FCF Ratio	-0.98	-1.28	-0.81	-0.46	-0.64	-0.43
Quick Ratio	3.01	3.46	2.47	3.75	7.85	8.98
Current Ratio	3.20	3.63	2.54	3.75	7.85	9.00
Asset Turnover	0.43	0.49	0.21	0	0	0
Interest Coverage	-55.54	-35.93	-24.51	-21.89	-39.12	-54.25
Return on Equity (ROE)	-134.20%	-112.40%	-252.20%	-230.70%	-73.60%	-120.30%
Return on Assets (ROA)	-50.50%	-43.70%	-79.70%	-101.40%	-52.90%	-75.20%
Return on Capital (ROIC)	-87.95%	-61.44%	-88.03%	-190.86%	-60.48%	-33.85%
Earnings Yield	-7.91%	-6.35%	-5.59%	-9.16%	-3.38%	-1.92%
FCF Yield	-5.16%	-3.87%	-3.50%	-7.62%	-2.58%	-1.30%
Buyback Yield / Dilution	-8.89%	-11.73%	-8.07%	-1.11%	-9.37%	-26.55%
Total Shareholder Return	-8.89%	-11.73%	-8.07%	-1.11%	-9.37%	-26.55%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).